Chikungunya crisis: Reinforcing One Health defenses against ecological pandemics

Conflict of interest statement

The author, Professor Jiahai Lu, serves as the Editor-in-Chief of One Health Bulletin. The views expressed are his own and do not necessarily represent the view of the Journal. To ensure the integrity and impartiality of the peer review process, this manuscript was handled and reviewed independently by the journal’s editorial team, with no involvement from Professor Lu. The author declares no other competing interests.

Funding

This study received no extramural funding.

Disclaimer

The author contributed to this article in his personal capacity. The views expressed are his own and do not necessarily represent the view of the institutions he is affiliated with.

Data availability statement

The data supporting the findings of this study are available from the corresponding author upon request.

References

[1] Xuhou Chen. The number of Chikungunya fever cases in Foshan has exceeded 4,000, and cases have emerged in Guangzhou, Yangjiang, Zhanjiang and other places. [Online] Available from: https://www.thepaper.cn/newsDetail_forward_31247988. [Accessed on 26th July 2025]. (in Chinese)

[2] World Health Organization. Chikungunya. [Online] Available from: https://www.who.int/news-room/fact-sheets/detail/chikungunya. [Accessed on 26th July 2025].

[3] Burt FJ, Chen W, Miner JJ, Lenschow DJ, Merits A, Schnettler E, et al. Chikungunya virus: An update on the biology and pathogenesis of this emerging pathogen. Lancet Infect Dis 2017; 17(4): e107-e117.

[4] Feng X, Sun W, Birkhead GS, Wang XZ, Guo ZM, Lu JH. The surveillance of four mosquito-borne diseases in international travelers arriving at Guangzhou Baiyun International Airport, China, 2016-2017. Travel Med Infect Dis 2019; 32: 101513.

[5] Li QL, Dai J, Shi YX, Deng Q, Liao CH, Huang JC, et al. IgM-specific linear epitopes on the E2 protein for serodiagnosis of chikungunya. Virus Res 2024; 339: 199292.

[6] Li QL, Zhang JS, Deng Q, Liao CH, Qian J, Chen ZL, et al. A divalent chikungunya and Zika nanovaccine with thermostable self-assembly multivalent scaffold LS-SUMO. Adv Healthc Mater 2024; 13(13): e2303619.

[7] Deng Q, Guo Z, Hu H, et al. Inhibition of chikungunya virus early replication by intracellular nanoantibodies targeting nsP2 Epitope Rich Region. Antiviral Res 2022; 208: 105446.

[8] Deng Q, Lu JH. One health and human health. Sci Bull 2022; 67: 37-46. (in Chinese)

[9] Wenzhou Medical University. Wenzhou Medical University Leads Global “One Health” Governance New Practice-2025 International Symposium Facilitates the Implementation of the “Pengcheng Declaration”. [Online] Available from: https://news.wmu.edu.cn/show/2/41824.html. [Accessed on 26th July 2025].

[10] Valneva. Valneva’s single-shot chikungunya vaccine-IXCHIQ®/ VLA1553. [Online] Available from: https://valneva.com/research-development/chikungunya/. [Accessed on 26th July 2025].